Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Consolidation is expected to continue in the upcoming sessions, with resistance and support at last week's high-low. Below are some short-term trading ideas to consider.
The benchmark indices are expected to consolidate in the upcoming sessions and look for fresh triggers. Below are some trading ideas for the near term.
According to experts, the Nifty 50 is likely to march towards the 24,300-24,500 zone if it manages to hold above 24,100 in the coming sessions. However, breaking below 24,100 could drag it down towards the 24,000-23,900 zone. Here are some trading ideas for the near term.
Viraj Vyas advises creating a non-directional spread in Nifty50 by selling 1 lot of 19,100PE and 1 lot of 19,500CE.
Volatility index (India VIX) was up 3.2 percent this week. The BSE largecap index rose 0.69 percent, midcap gained 0.36 percent, while smallcap was down 1.27 percent
Rajesh Agarwal of AUM Capital recommends buying Hindustan Oil Exploration with stop loss at Rs 140 and target of Rs 149, Marksans Pharma with stop loss at Rs 31 and target of Rs 37 and Liberty Shoes with stop loss at Rs 206 and target of Rs 233.
Sharmila Joshi of sharmilajoshi.com is of the view that one may hold Marksans Pharma.
The pharma companies have posted mix earnings in the quarter ended September 2017 on the back pricing pressure and increased competition.
Analysts were expecting some sort of bounce back which has come considering the fact benchmark indices were trading near crucial support levels.
Sharmila Joshi of sharmilajoshi.com is of the view that is of the view that one may prefer Glenmark Pharma, Sun Pharmaceutical and Lupin.
Rajat Bose of rajatkbose.com feels that Marksans Pharma may test Rs 48.
Sandeep Wagle of powermywealth.com is of the view that one can buy Power Grid..
Rajesh Agarwal of AUM Capital suggests buying Power Grid.
Vijay Chopra of enochventures.com is of the view that one may prefer Sun Pharmaceutical Industries.
Mitessh Thakkar of miteshthacker.com is of the view that one can buy Grasim Industries and Petronet LNG.
According to Gaurang Shah of Geojit Financial Services, one may prefer Cipla and Aurobindo Pharma.
Marksans Pharma, on February 20, announced that it has successfully completed UK MHRA inspection for its Goa facility without any critical observations. The company is now awaiting further instruction from the agency on the way forward
Mitessh Thakkar of miteshthacker.com recommends buying Marksans Pharma and Pidilite Industries.
Sameet Chavan of Angel Broking is of the view that one may buy JSW Steel with a target of Rs 1750.
Rajat Bose of rajatkbose.com is of the view that one may stay invested in Marksans Pharma.
Sharmila Joshi of sharmilajoshi.com is positive on Marksans Pharma.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Bharti Infratel, Mahindra & Mahindra Financial Services, Nahar Spinning and Capital First.
Mitesh Thacker of miteshthacker.com is of the view that one can buy Marksans Pharma and IRB Infra and sell Hindustan Unilever and Hexaware Technologies.
Sharmila Joshi of sharmilajoshi.com is of the view that one may stay invested in pharma space with long term view.
Rajat Bose of rajatkbose.com suggests exiting Marksans Pharma.